TABLE II.
Clinical characteristics of control, type 1 diabetic (including pre-eclamptic) and type 2 diabetic patients across pregnancy, and of pre-eclamptic patients in the third trimester.
| Control (n=10) | Type 1 Diabetic (n=9) | Type 2 Diabetic (n=3) | Pre-Eclamptic (n=2) | |
|---|---|---|---|---|
| Blood Pressure (mmHg) | 115/73 (± 1.9/1.3) | 122/73 (± 2.7/2.0) | 133/87 (± 14.5/3.3) | 142/87 (± 10.5/8.5) |
| Blood Glucose (mmol/L) | NAD | 8.7 (± 1.2) | 10.1 (± 0.0) | NM |
| HbA1C (% of Hb) | NAD | 7.9 (± 0.6) | NM | NM |
| Urine protein/24 hour (mg/dL) | 4.0 (± 3.0) | 63.3 (± 27.2) | 0.0 (± 0.0) | 15.0 (± 15.0) |
Data are mean ± SEM. Both PE patients are type 1 diabetic. Hb, hemoglobin. NAD, no abnormality detected. NM, not measured. Normal ranges for blood glucose (3.3–5.6 mmol/L) and HbA1C (3.6–5.0% of Hb). Trace values for urine protein/24 hour are 5–20 mg/dL.